World TB Day: Vaccine trial inspires SATVI clinicians to imagine a world without TB

24 March 2023 | VP Team Ruairi Abrahams, Boikhutso Ntsoko, Roxanne Harris and Rozanne Engel. Videography Ruairi Abrahams and Boikhutso Ntsoko. Video Edit Ruairi Abrahams. Photo Lerato Maduna.

On World TB Day, the University of Cape Town (UCT) shines the spotlight on phase three of a clinical trial led by clinicians at the South African Tuberculosis Vaccine Initiative (SATVI).

The study aims to explore and assess the safety, immunogenicity and efficacy of the novel MTBVAC as a potential TB vaccine alternative to the age-old bacille Calmette-Guerin (BCG), currently administered at birth to protect babies from TB.

Creative Commons License This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

Please view the republishing articles page for more information.